|本期目录/Table of Contents|

[1]杨祎,司晓雪,邵楚茜,等.健脾祛痰化瘀法防治动脉粥样硬化的临床研究进展[J].环球中医药,2015,8(09):1130-1135.[doi:10.3969/j.issn.1674-1749.2015.09.030]
　YANG Yi,SI Xiao-xue,SHAO Chu-qian,et al.Advances in the clinical researches of treating atherosclerosis via the method of invigorating spleen, removing phlegm and eliminating blood statisis[J].,2015,8(09):1130-1135.[doi:10.3969/j.issn.1674-1749.2015.09.030]
点击复制

健脾祛痰化瘀法防治动脉粥样硬化的临床研究进展()
     
分享到：

《环球中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
第8卷
期数:
2015年09期
页码:
1130-1135
栏目:
综述
出版日期:
2015-09-06

文章信息/Info

Title:
Advances in the clinical researches of treating atherosclerosis via the method of invigorating spleen, removing phlegm and eliminating blood statisis
作者:
杨祎; 司晓雪; 邵楚茜; 陈阳; 赵丹玉; 贾连群
110847 沈阳,辽宁中医药大学第一临床学院
Author(s):
YANG Yi;  SI Xiao-xue;  SHAO Chu-qian;  et al.
The First Clinical College, Liaoning University of Chinese Medicine, Shenyang 110847, China Corresponding
关键词:
健脾;  化痰;  祛瘀;  动脉粥样硬化
Keywords:
Invigorating spleen;  Removing phlegm;  Eliminating blood stasis;  Atherosclerosis
分类号:
R259
DOI:
10.3969/j.issn.1674-1749.2015.09.030
文献标志码:
-
摘要:
对健脾祛痰化瘀法防治动脉粥样硬化的研究进行了文献整理和分析,以健脾、祛痰、化瘀、动脉粥样硬化等为主题词进行了文献检索。从血脂、免疫炎症、抗氧化和血管张力调节这4方面总结了中药防治动脉粥样硬化的研究进展。并且从上述4方面内容,对近10年来的动物实验和临床随机对照实验进行了分析归纳。健脾祛痰化瘀类方剂对动脉粥样硬化患者的血脂紊乱状态有显著地纠正作用,并且也有抗炎、抗氧化应激与舒张血管作用。进一步探讨了此类方剂防治动脉粥样硬化的优势,以及开发此类方剂对于中医药防治动脉粥样硬化的广阔前景。
Abstract:
In this review, current researches on the TCM drug therapies of atherosclerosis via the method of invigorating spleen, removing phlegm and eliminating stagnated blood were summarized and analyzed.These methods and atherosclerosis were used as key words for literature search. We analyze animal experiments and RCT studies of the recent 10 years in 4 aspects:inflammations,dyslipidemia,antioxidation as well as angiotasis regulation.It turns out that: this kind of therapy plays a very important role in correcting dyslipidemia,anti-inflammtion as well as antioxidation and vasodilatation.However,our scholars concentrate more on its correction of dyslipidemia.We also further discuss the advantages of this therapy and its spectacular prospects for treating and protecting atherosclerosis.

参考文献/References:

［1］ Lee Goldman, Andrew I.Schafer. Goldman's Cecil Medicine [M].24th edition. Singapore:Elsevier Pre Ltd,2012:409.
［2] 贾连群,杨关林.从“脾主运化”理论探讨膏脂转输与胆固醇逆向转运[J].中医杂志,2013,54(20):1793-1794.
［3] 李翼,邓中甲,连建伟,等.方剂学[M].北京:中国中医药出版社,2006:1.
［4] 李玉林,文继舫,唐建武. 病理学[M]. 7版.北京:人民卫生出版社,2008:115.
［5] 柴晶艳 王昕 包春辉.丹蒌片治疗冠心病心绞痛疗效观察[J]. 中国民族民间医药,2009,17(1):126.
［6] 彭彩亮,蒋宁,高嵩山等.两种常用中药制剂联合常规西医疗法治疗稳定性心绞痛的疗效对比[J].黑龙江中医药,2011,40(3):27-28.
［7］ 韩为民.健脾化痰活血法结合西药治疗2 型糖尿病合并高脂血症疗效观察 [J].上海中医药杂志,2013,47(8):42-43.
［8] 刘婷,肖振东,李培培.理气化痰祛瘀法治疗冠心病合并高脂血症(痰瘀互阻证)45例[J].中国实验方剂学杂志,2014,20(8):221-225.
［9] 魏玲玲.健脾化痰通脉方治疗冠心病血脂异常30例临床观察[J].中西医结合心血管杂志,2011,9(6):647-649.
［10] 李知玉,吴其恺,何清,等.健脾化痰祛瘀中药联合干扰素治疗慢性乙型肝炎合并非酒精性脂肪肝临床观察[J].世界中西医结合杂志,2010,5(3):222-224.
［11] 陈镇秋,何伟,魏秋实.“痰瘀同治”对酒精性股骨头坏死患者血液流变学及血脂水平的影响[J].中华中医药杂志,2012,27(1):246-248.
［12] 马雅銮,王亚红,韩俊燕.祛痰化瘀解毒方药对高脂血症痰瘀互阻证患者单核细胞亚群异常的影响[J].中国中西医结合杂志,2011,31(1):23-26.
［13] Berglund L, Brunzell JD, Goldberg AC, et al. Evaluationand treatment of hypertriglyceridemia: an Endocrine Societyclinical practice guideline[J]. J Clin Endocrinol Metab, 2012,97(9):2969-2989.
［14] 黄雯晖.痰痕同治干预2型糖尿病痰痕证患者相关炎症因子TNF-a、CRP的临床研究[J].中医临床研究,2011,3(9):1-3.
［15] 吉金荣,高彩霞,罗清菊.化痰祛瘀改善稳定型心绞痛患者血管内皮功能的临床研究 [J].光明中医,2012,27(6):1127-1128.
［16] 毛威.痰瘀同治颗粒对冠心病PPAR,MCP-1,hs-CRP表达的影响[J].光明中医,2012,27(6):1127-1128.
［17] 王师菡,王阶,李霁,等.丹蒌片治疗痰瘀互阻型冠心病心绞痛的疗效评价[J].中国中西医结合杂志,2012,32(8):1051-1055.
［18] Koenig W, Khuseyinova N, Lowel H, et al.Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactiveprotein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany[J]. Circulation, 2004,(110):1903-1908.
［19] 戴金.痰瘀同治颗粒对冠心病痰瘀互结证中医证候和PPARγ表达的影响[J].中华中医药杂志,2010,25(7):1112-1114.
［20] 朱宏勋,黄粤,曹锐.化痰祛瘀汤对急性缺血性中风病患者hs-CRP、MMP-9 的影响[J].北京中医药,2014,33(8):584-586.
［21] Piemonti L1, Leone BE, Nano R, et al. human pancreatic islets produce and secrete MCP-1/CCL2:relecance in human islet transplantation.[J].Diabetes,2002,51(1):55-65.
［22] 蒋文静,陈瑞侠,杨莎,等.益气养阴、祛痰化瘀法对2型糖尿病的防治作用研究[J].中国医药指南,2013,(1):585-586.
［23] Auffray C,Fogg D,Garfa M, et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior[J]. Science,2007,317( 5838): 666-670.
［24] 方美凤,谭峰,张圻等.化痰通络颗粒对脑梗死患者外周血细胞因子信号转导抑制因子-3及肿瘤坏死因子-α的影响[J].中国中西医结合杂志,2010,30(11):1142-1145.
［25] 季聚良.益气健脾、化痰祛瘀法对2型糖尿病患者B细胞功能的影响[C]//中华中医药学会内科分会消渴病第七届学术研讨会论文集,2011:44-47.
［26] 黄月芳,楼招欢,陈坚翱.化痰通络汤合牵正散对风痰瘀血痹阻证急性脑梗死患者同型半胱氨酸的影响及临床疗效观察[J].中华中医药杂志,2013,28( 6): 1907-1910.
［27] 王朝霞, 方习红, 王鹏.祛痰化瘀胶囊治疗痰瘀阻络型脑梗死急性期100 例[J].中西医结合心脑血管病杂志,2009,7(4): 1051-1055.
［28] 于兴娟.益气活血化痰汤治疗缺血性中风的临床研究[D].济南:山东中医药大学,2006.
［29] Mujynya-Ludunge K,Viswambharan H,Driscoll R.Endothelial nitric oxide synthase gene transfer restoresendothelium-dependent relaxations and attenuates lesionformation in carotid arteries in apolipoprotein E-deficientmice[J]. Basic Res Cardiol,2005,100(2): 102.
［30] Boutque S L,Davidge S T,Adams M A. The interactionbetween endothelin-1 and nitric oxide in the vasculature:new perspectives[J]. Am J Physiol Regul Integr CompPhysiol,2011,300(6):R1288.
［31] 叶穗林,叶玺, 高雅琦.加味温胆汤对痰瘀证高血压病患者血管内皮功能障碍的影响[J].广州医药,2011,42(5):49-51.
［32] 吉金荣,高彩霞,孙金梅. 丹蒌片对代谢综合征患者血管内皮功能的影响 [J].中国实用医药,2012,7(25):172-174.
［33] 苏健,焦惠霞.益气健脾活血化瘀法对子宫腺肌病继发痛经患者经血中血管舒缩因子及激素的影响[J].四川中医,2014,32(8):72-74.
［34] 吴广平,祁建勇.邓铁涛教授治疗冠心病药物统计分析 [J].辽宁中医药大学报,2013,15(1):120-122.
［35] 赵红.邓老冠心方对冠心病(痰瘀型)血小板聚集率影响的临床研究 [D].广州:广州中医药大学,2011:15.
［36] 麻志恒, 张汉新, 高志生等.化瘀祛痰汤治疗脑梗塞的临床疗效观察[J].中成药,2009,31(2):177-179.

相似文献/References:

备注/Memo

备注/Memo:
-
更新日期/Last Update: 1900-01-01